A GM-CSF and CD40L bystander vaccine is effective in a murine breast cancer model

BACKGROUND: There is increasing interest in using cancer vaccines to treat breast cancer patients in the adjuvant setting to prevent recurrence in high risk situations or in combination with other immunomodulators in the advanced setting. Current peptide vaccines are limited by immunologic compatibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Soliman, Hatem, Mediavilla-Varela, Melanie, Antonia, Scott J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687618/
https://www.ncbi.nlm.nih.gov/pubmed/26719725
http://dx.doi.org/10.2147/BCTT.S89563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687618/
https://www.ncbi.nlm.nih.gov/pubmed/26719725
http://dx.doi.org/10.2147/BCTT.S89563

Ejemplares similares